Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Biobetters Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Diabetes
  • 1.4.3 Growth Hormone
  • 1.4.4 Cancer
  • 1.4.5 Renal Disease
  • 1.4.6 Others
• 1.5 Market by Application
  • 1.5.1 Global Biobetters Market Share by Application (2014-2025)
  • 1.5.2 Biopharmaceutical
  • 1.5.3 Contract Research Organizations
  • 1.5.4 Research Institutes
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Biobetters Market Size
• 2.2 Biobetters Growth Trends by Regions
  • 2.2.1 Biobetters Market Size by Regions (2014-2025)
  • 2.2.2 Biobetters Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Biobetters Market Size by Manufacturers
  • 3.1.1 Global Biobetters Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Biobetters Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Biobetters Market Concentration Ratio (CR5 and HHI)
• 3.2 Biobetters Key Players Head office and Area Served
• 3.3 Key Players Biobetters Product/Solution/Service
• 3.4 Date of Enter into Biobetters Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Biobetters Market Size by Type (2014-2019)
• 4.2 Global Biobetters Market Size by Application (2014-2019)

5 United States

• 5.1 United States Biobetters Market Size (2014-2019)
• 5.2 Biobetters Key Players in United States
• 5.3 United States Biobetters Market Size by Type
• 5.4 United States Biobetters Market Size by Application

6 Europe

• 6.1 Europe Biobetters Market Size (2014-2019)
• 6.2 Biobetters Key Players in Europe
• 6.3 Europe Biobetters Market Size by Type
• 6.4 Europe Biobetters Market Size by Application

7 China

• 7.1 China Biobetters Market Size (2014-2019)
• 7.2 Biobetters Key Players in China
• 7.3 China Biobetters Market Size by Type
• 7.4 China Biobetters Market Size by Application

8 Japan

• 8.1 Japan Biobetters Market Size (2014-2019)
• 8.2 Biobetters Key Players in Japan
• 8.3 Japan Biobetters Market Size by Type
• 8.4 Japan Biobetters Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Biobetters Market Size (2014-2019)
• 9.2 Biobetters Key Players in Southeast Asia
• 9.3 Southeast Asia Biobetters Market Size by Type
• 9.4 Southeast Asia Biobetters Market Size by Application

10 India

• 10.1 India Biobetters Market Size (2014-2019)
• 10.2 Biobetters Key Players in India
• 10.3 India Biobetters Market Size by Type
• 10.4 India Biobetters Market Size by Application

11 Central & South America

• 11.1 Central & South America Biobetters Market Size (2014-2019)
• 11.2 Biobetters Key Players in Central & South America
• 11.3 Central & South America Biobetters Market Size by Type
• 11.4 Central & South America Biobetters Market Size by Application

12 International Players Profiles

• 12.1 OPKO
  • 12.1.1 OPKO Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Biobetters Introduction
  • 12.1.4 OPKO Revenue in Biobetters Business (2014-2019)
  • 12.1.5 OPKO Recent Development
• 12.2 Abzena
  • 12.2.1 Abzena Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Biobetters Introduction
  • 12.2.4 Abzena Revenue in Biobetters Business (2014-2019)
  • 12.2.5 Abzena Recent Development
• 12.3 Arecor
  • 12.3.1 Arecor Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Biobetters Introduction
  • 12.3.4 Arecor Revenue in Biobetters Business (2014-2019)
  • 12.3.5 Arecor Recent Development
• 12.4 GLYCOTOPE
  • 12.4.1 GLYCOTOPE Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Biobetters Introduction
  • 12.4.4 GLYCOTOPE Revenue in Biobetters Business (2014-2019)
  • 12.4.5 GLYCOTOPE Recent Development
• 12.5 CEVEC
  • 12.5.1 CEVEC Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Biobetters Introduction
  • 12.5.4 CEVEC Revenue in Biobetters Business (2014-2019)
  • 12.5.5 CEVEC Recent Development
• 12.6 Antares Pharma
  • 12.6.1 Antares Pharma Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Biobetters Introduction
  • 12.6.4 Antares Pharma Revenue in Biobetters Business (2014-2019)
  • 12.6.5 Antares Pharma Recent Development
• 12.7 Amgen
  • 12.7.1 Amgen Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Biobetters Introduction
  • 12.7.4 Amgen Revenue in Biobetters Business (2014-2019)
  • 12.7.5 Amgen Recent Development
• 12.8 Novo Nordisk
  • 12.8.1 Novo Nordisk Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Biobetters Introduction
  • 12.8.4 Novo Nordisk Revenue in Biobetters Business (2014-2019)
  • 12.8.5 Novo Nordisk Recent Development
• 12.9 Roche
  • 12.9.1 Roche Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Biobetters Introduction
  • 12.9.4 Roche Revenue in Biobetters Business (2014-2019)
  • 12.9.5 Roche Recent Development
• 12.10 Biogen
  • 12.10.1 Biogen Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Biobetters Introduction
  • 12.10.4 Biogen Revenue in Biobetters Business (2014-2019)
  • 12.10.5 Biogen Recent Development
• 12.11 Pfizer
• 12.12 Eli Lilly

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

The term biobetter refers to a recombinant protein drug that is in the same class as an existing biopharmaceutical but is not identical; it is improved over the original. Biobetters build on the success of existing, approved biologics but are considered less of a commercial risk than developing a brand new class of biologic.
Biobetters are more effective than any other biological entities, the demand of biobetters is much higher as the target action is high and the players are working on development of biobetters in large scale to increase the product availability and also investing larger share in innovation to come up with various product segment for multiple application. Biobetters are very help full in novel biological developing for treating disease such as anemia, prevention of bleeding incidents in children, adult suffering from haemophilia A, cancer and other related problems. As the disease prevalence is increase and various break-out are occurring in various region which cause multiple disorder to populations. The biobetters help in bioengineering to develop product platform for product development in treating diseases.
In 2018, the global Biobetters market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Biobetters status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biobetters development in United States, Europe and China.

The key players covered in this study
OPKO
Abzena
Arecor
GLYCOTOPE
CEVEC
Antares Pharma
Amgen
Novo Nordisk
Roche
Biogen
Pfizer
Eli Lilly

Market segment by Type, the product can be split into
Diabetes
Growth Hormone
Cancer
Renal Disease
Others

Market segment by Application, split into
Biopharmaceutical
Contract Research Organizations
Research Institutes

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Biobetters status, future forecast, growth opportunity, key market and key players.
To present the Biobetters development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Biobetters are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.